Risk adjusted net present value: What is the current valuation of AstraZeneca’s Saruparib?

Saruparib is a small molecule commercialized by AstraZeneca, with a leading Phase III program in Metastatic Prostate Cancer.

Source link
#Risk #adjusted #net #present #current #valuation #AstraZenecas #Saruparib